ClinConnect ClinConnect Logo
Search / Trial NCT06389409

Study on the Quality of Life and Functional/Oncological Outcome of Testicular Cancer Patients

Launched by IRCCS SAN RAFFAELE · Apr 26, 2024

Trial Information

Current as of November 13, 2025

Recruiting

Keywords

Testicular Cancer

ClinConnect Summary

This clinical trial is focused on understanding the quality of life and health outcomes for men diagnosed with testicular cancer. Researchers aim to gather important information about the challenges faced by these patients and create a comprehensive database to enhance the knowledge of this disease. The ultimate goal is to improve how testicular cancer is diagnosed and treated.

To participate in this study, men must be over 18 years old and have a suspected or confirmed case of testicular cancer that requires surgery. Participants should also be able to understand the study and give their consent to join. During the trial, participants can expect to share their experiences and symptoms related to their condition, which will help researchers develop better care strategies. This study is currently recruiting participants, so if you or someone you know fits the criteria, it could be a valuable opportunity to contribute to important cancer research.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • subjects suffering from suspected neoplastic testicular pathology candidates for testicle removal surgery
  • patients suffering from neoplastic testicular pathology requiring removal of the retroperitoneal lymph nodes
  • subjects \> 18 years old
  • subjects with at least elementary education
  • signature of informed consent
  • Exclusion Criteria:
  • subjects \< 18 years
  • presence of mental or physical disability that may prevent the patient from satisfying the requirements of the protocol

About Irccs San Raffaele

IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.

Locations

Milan, Lombardy, Italy

Patients applied

0 patients applied

Trial Officials

Andrea Salonia, MD

Principal Investigator

IRCCS Ospedale San Raffaele

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported